X-SCID Gene Therapy Risks Not Generalizable To Other Conditions, Cmte. Says

FDA's Cellular, Tissue & Gene Therapies Advisory Committee points to unique factors in the biological basis of X-linked severe combined immunodeficiency disorder and the fact that leukemia cases have been seen in only one study.